252 related articles for article (PubMed ID: 33356836)
41. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
[TBL] [Abstract][Full Text] [Related]
42. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
43. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
44. A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.
Sinha VC; Qin L; Li Y
Mol Cancer Res; 2015 Feb; 13(2):231-8. PubMed ID: 25253740
[TBL] [Abstract][Full Text] [Related]
45. Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Bahram F; Hydbring P; Tronnersjö S; Zakaria SM; Frings O; Fahlén S; Nilsson H; Goodwin J; von der Lehr N; Su Y; Lüscher B; Castell A; Larsson LG
Oncotarget; 2016 Jan; 7(3):2837-54. PubMed ID: 26701207
[TBL] [Abstract][Full Text] [Related]
46. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells.
Ramljak D; Coticchia CM; Nishanian TG; Saji M; Ringel MD; Conzen SD; Dickson RB
Exp Cell Res; 2003 Jul; 287(2):397-410. PubMed ID: 12837294
[TBL] [Abstract][Full Text] [Related]
48. [In vitro study of BRD4 inhibitor GSK525762A against primary adult common B-cell acute lymphoblastic leukemia cells in vitro].
Ma S; Chen C; Zhu J; Li Y; Wang X; Song X; Cao J; Xu K
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):563-9. PubMed ID: 26304078
[TBL] [Abstract][Full Text] [Related]
49. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
50. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo.
Tian LL; Yue W; Zhu F; Li S; Li W
J Cell Physiol; 2011 Jul; 226(7):1860-7. PubMed ID: 21442622
[TBL] [Abstract][Full Text] [Related]
51. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
52. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
[TBL] [Abstract][Full Text] [Related]
53. MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.
Labisso WL; Wirth M; Stojanovic N; Stauber RH; Schnieke A; Schmid RM; Krämer OH; Saur D; Schneider G
Cell Cycle; 2012 Apr; 11(8):1593-602. PubMed ID: 22456335
[TBL] [Abstract][Full Text] [Related]
54. The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
O'Hara SP; Splinter PL; Trussoni CE; Guicciardi ME; Splinter NP; Al Suraih MS; Nasser-Ghodsi N; Stollenwerk D; Gores GJ; LaRusso NF
J Biol Chem; 2019 Dec; 294(49):18698-18713. PubMed ID: 31659122
[TBL] [Abstract][Full Text] [Related]
55. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
56. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
[TBL] [Abstract][Full Text] [Related]
57. Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer.
Jian Y; Huang X; Fang L; Wang M; Liu Q; Xu H; Kong L; Chen X; Ouyang Y; Wang X; Wei W; Song L
J Exp Clin Cancer Res; 2021 Feb; 40(1):56. PubMed ID: 33541412
[TBL] [Abstract][Full Text] [Related]
58. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
59. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
60. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]